Total raised
—
Stage
Pre-Funding
Founded
2020
Headcount
5
HQ
Herzliya
Sector
Health Tech & Life Sciences
About
Taxon Therapeutics is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins for rare autoimmune diseases with unmet need. The company's product, TAX-01, is designed for the treatment of adults with autoimmune hemolytic anemia, a severe and rare blood disorder that occurs when antibodies directed against the person's own red blood cells cause them to burst, leading to an insufficient number of oxygen-carrying red blood cells in circulation.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
therapeuticsrare-diseasesbiotechnologyautoimmune-diseasespharmaceuticalsdrug-developmenthematologyorphan-drug